Top Markets
#1 Siren Siren +33.48%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.74%
#4 Nockchain Nockchain +18.17%
#5 Ribbita by Virtuals Ribbita by Virtuals +17.65%
#6 TRIA TRIA +17.53%
#7 PulseChain PulseChain +16.92%
#8 Velvet Velvet +16.25%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.81%
#10 Bitway Bitway +15.30%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Clasificación en acciones #31230
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Precio por acción
$0.01084256
Capitalización bursátil
$13.87M
Cambio (1 día)
0.00%
Cambio (1 año)
1.70%
País
NZ
Comercio BLIS Technologies Limited (BLT)

Categoría

Healthcare
Ganancias de BLIS Technologies Limited (BLT)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BLIS Technologies Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de BLIS Technologies Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE